Jump to Main Contents
ncc en

Home > Information > Hiroyoshi Nishikawa Honoured with the 2020 SITC ‘Team Science Award’

Hiroyoshi Nishikawa Honoured with the 2020 SITC ‘Team Science Award’

17 November 2020
in Japanese
Dr. Nishikawa image

Dr Hiroyoshi Nishikawa, Chief - Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center (doubly appointed Professor - Department of Immunology, Nagoya University Graduate School of Medicine) was conferred the 2020 SITC Team Science Award.The honour was in recognition to his work as a member of the team lead by the late Lloyd J. Old, MD, who established the research field of cancer immunology.

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. The winner of the 2015 was Dr James Allison’s group which won the 2018 Novel Prize in Physiology or Medicine with Dr Tasuku Honjo, Deputy Director-General and Distinguished Professor, Institute for Advanced Study Kyoto University.
https://www.sitcancer.org/funding/awards/anniversaryawards/sitc2015 (linked to extenal site)

SITC

35th Anniversary Awards
https://www.sitcancer.org/funding/awards/anniversaryawards/sitc2020 (linked to extenal site)

Hiroyoshi Nishikawa

Positions and Employment

1989-1995     Mie University School of Medicine, M.D., Mie, Japan
1995              Junior Resident, Mie University Hospital, Mie, Japan 
1995-1997     Junior Resident, Matsusaka-Chuo General Hospital, Mie, Japan
1997-1998     Senior Resident, Hematology/Oncology Section, Suzuka General Hospital, Mie, Japan
1998-2002     Mie University Graduate School of Medicine, Ph.D., Mie, Japan
2002-2003     Fellow, Department of Hematology/Oncology, Mie University Hospital, Mie Japan.
2003-2006     Research fellow, Memorial Sloan Kettering Cancer Center, New York, NY
2006-2010     Assistant Professor, Department of Cancer Vaccine, Mie University,
                     Graduate School of Medicine, Mie, Japan
2010-2015     Associate Professor, Experimental Immunology, IFReC, Osaka University, Osaka, Japan
2012-2015     Adjunct Associate Professor, Department of Oncology, Roswell Park Cancer Institute, Buffalo, NY
2015-present  Chief, Division of Cancer Immunology, Research Institute / EPOC
                     National Cancer Center, Tokyo/Chiba, Japan
2016-present  Professor, Department of Immunology,
                     Nagoya University Graduate School of Medicine, Nagoya, Japan

Specialty/Research field

Immunology,Oncology, particularly Tumor Immunology